Agree totally with you but we can't blame the majority of traders today who give a damn about it, their business is the profitable in and out of a stock regardless of what it does.
I am excited by the immune system response and its re-attacking the re-introduced cancer without stimulus. Exactly the same success as IMU's CF33 OV - the holy grail.
That has to be digested but those who never did any research on this topic aren't able to understand the significance. Killing the cancer from the outside for a period of time is one thing, keeping it down for ever is another. That's what attracts big pharma's money.
Despite the above, patience is required.
The sp could have another leap to, imo, fair value at 5-6c or get smashed by profit takers, anything is possible.
Value estimation: similar techs were bought out recently for at least USD 500m / AUD 670m. Just applying AUD 300m, max 6b shares = 5c
GLTA
IVX Price at posting:
3.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)